Topic Editors

Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Via Vienna 2, 07100 Sassari, Italy
School of Science and Technology, Chemistry Division, University of Camerino, Via Sant’Agostino 1, 62032 Camerino, Italy
School of Science and Technology, Chemistry Division, University of Camerino, Via Sant’Agostino 1, 62032 Camerino, Italy

Metal Ions in Health and Diseases: Current Progress and Future Challenges

Abstract submission deadline
closed (31 March 2025)
Manuscript submission deadline
31 May 2025
Viewed by
970

Topic Information

Dear Colleagues,

Metal ions play a pivotal role in numerous physiological processes within the human body, ranging from enzyme activation to cellular signaling. However, dysregulation in metal ion homeostasis has been implicated in various health conditions and diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer. The study of metal ions in health and diseases represents a burgeoning field of research, with significant implications for both diagnosis and treatment.

Recent advances in analytical techniques have facilitated the detection and quantification of metal ions in biological samples, enabling researchers to better understand their roles in disease pathogenesis and the underlying molecular mechanisms involved. Moreover, studies exploring the therapeutic potential of metal ion chelators and modulators have provided promising avenues for the development of novel treatments.

Despite these advancements, numerous challenges persist. For instance, elucidating precise mechanisms of metal ion dysregulation, developing effective targeting and modulation strategies, overcoming analytical limitations, discovering reliable biomarkers, and translating findings into clinically viable treatments. Additionally, understanding interactions with other biological factors and bridging the gap between basic research and clinical applications are key challenges in this field. The current topic aims to provide a platform for researchers to disseminate their findings and insights into the role of metal ions in health and diseases. We invite manuscripts that delve into the multifaceted realm of metal ion biology, spanning from the intricate coordination chemistry of metal ions within biological systems to their pivotal roles in disease pathogenesis, diagnostic modalities, and therapeutic strategies. Furthermore, we encourage submissions that explore emerging research frontiers, including the utilization of metal nanoparticles in cutting-edge biomedical applications like targeted drug delivery and advanced imaging techniques.

Dr. Massimiliano F. Peana
Prof. Dr. Carlo Santini
Dr. Maura Pellei
Topic Editors

Keywords

  • metal ions
  • coordination chemistry
  • metal ion homeostasis
  • neurodegenerative disorders
  • cardiovascular diseases
  • cancer
  • analytical techniques
  • therapeutic strategies
  • metal nanoparticles
  • biomedical applications of metal complexes

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Chemistry
chemistry
2.4 3.2 2019 17.2 Days CHF 1800 Submit
Molecules
molecules
4.2 7.4 1996 15.1 Days CHF 2700 Submit
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 16.8 Days CHF 2900 Submit
Biomolecules
biomolecules
4.8 9.4 2011 18.4 Days CHF 2700 Submit
Inorganics
inorganics
3.1 2.8 2013 15.8 Days CHF 2200 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
29 pages, 7203 KiB  
Article
New Cu(II), Cu(I) and Ag(I) Complexes of Phenoxy-Ketimine Schiff Base Ligands: Synthesis, Structures and Antibacterial Activity
by Miriam Caviglia, Zhenzhen Li, Carlo Santini, Jo’ Del Gobbo, Cristina Cimarelli, Miao Du, Alessandro Dolmella and Maura Pellei
Molecules 2025, 30(9), 1893; https://doi.org/10.3390/molecules30091893 - 24 Apr 2025
Viewed by 159
Abstract
Two phenoxy-ketimines ligands, 2-(1-(benzylimino)ethyl)phenol (HLBSMe) and 2-((benzylimino)(phenyl)methyl)phenol (HLBSPh), were synthesized and used as supporting ligands of new copper(II), copper(I), and silver(I) complexes. In order to confer different solubility properties to the metal complexes and to stabilize Cu and Ag [...] Read more.
Two phenoxy-ketimines ligands, 2-(1-(benzylimino)ethyl)phenol (HLBSMe) and 2-((benzylimino)(phenyl)methyl)phenol (HLBSPh), were synthesized and used as supporting ligands of new copper(II), copper(I), and silver(I) complexes. In order to confer different solubility properties to the metal complexes and to stabilize Cu and Ag in their +1 oxidation state, the lipophilic triphenylphosphine (PPh3) and the hydrophilic 1,3,5-triaza-7-phosphaadamantane (PTA) were selected as co-ligands in the syntheses of the Cu(I) and Ag(I) complexes. All compounds were characterized by CHN analysis, NMR, FT-IR spectroscopy, and electrospray ionization mass spectrometry (ESI-MS); the molecular structure of the copper(II) complex [Cu(LBSPh)2] was also determined by single-crystal X-ray diffraction. Finally, the antibacterial activity of the metal complexes, the Schiff base ligands and phosphane co-ligands, were assessed by determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against Gram-negative (Escherichia coli) and Gram-positive bacteria (Staphylococcus aureus). Full article
Show Figures

Figure 1

Back to TopTop